Medical lens company STAAR Surgical (NASDAQ:STAA) will be reporting results this Wednesday afternoon. Here’s what to expect.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Haemonetics , Scholar Rock Holding and Ocugen . Claim 55% Off TipRanks. Unlock hed ...

Haemonetics beats Q4 EPS and revenue estimates, shares rise 1.4%, but gross margin falls 120 basis points as the company sets ...

The MHRA has approved donidalorsen for long-term prevention of hereditary angioedema, a rare disorder causing potentially life-threatening swelling.

Haemonetics (NYSE:HAE) reported fiscal fourth-quarter revenue of $346 million, up 5% on a reported basis and 9% organically ...

Q4 FY26 earnings call recap: revenue/EPS, FY27 guidance, Persona PLUS momentum, IVT inflection, and tariff risks—read now.

Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter fiscal year 2026, which ended March 28, 2026, are available on the Company's Investor Relations website at ...

BOSTON (AP) — BOSTON (AP) — Haemonetics Corp. (HAE) on Thursday reported a loss of $20.1 million in its fiscal fourth quarter. On a per-share basis, the Boston-based company said it had a loss of 44 ...

Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Bank of America 2026 Healthcare Conference on Tuesday, May ...

The most recent analyst rating on (HAE) stock is a Buy with a $70.00 price target. To see the full list of analyst forecasts on Haemonetics stock, see the HAE Stock Forecast page. According to Spark, ...

Italian pharma group Chiesi has bolstered its rare disease business with an agreement to buy US biopharma KalVista Pharma and ...

Chiesi Group is taking KalVista Pharmaceuticals under its wing, paying $1.9 billion for the biotech’s oral therapy Ekterly to ...